A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases

Treatments for women with recurrent brain metastases from breast cancer are limited. In this phase II study, we administered sagopilone to patients with breast cancer and brain metastases. We observed modest activity with a central nervous system objective response rate of 13.3%; however, median PFS...

Full description

Saved in:
Bibliographic Details
Main Authors: Freedman, Rachel A., Bullitt, Elizabeth, Sun, Lixian, Gelman, Rebecca, Harris, Gordon, Ligibel, Jennifer A., Krop, Ian E., Partridge, Ann H., Eisenberg, Emily, Winer, Eric P., Lin, Nancy U.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773692/
https://ncbi.nlm.nih.gov/pubmed/21697017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2011.03.024
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items